USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	058330/0536			Pages:	7
		Recorded:	12/08/2021
Attorney Dkt #:	2752
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 14

Patent #:	9249202	Issue Dt:	02/02/2016	Application #:	12377048	Filing Dt:	02/10/2009
Publication #:	US20100303866	Pub Dt:	12/02/2010
Title:	IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

Patent #:	8999346	Issue Dt:	04/07/2015	Application #:	12735740	Filing Dt:	08/13/2010
Publication #:	US20110002903	Pub Dt:	01/06/2011
Title:	IMMUNOGENIC CONTROL OF TUMOURS AND TUMOUR CELLS

Patent #:	9248171	Issue Dt:	02/02/2016	Application #:	12735744	Filing Dt:	08/13/2010
Publication #:	US20110110964	Pub Dt:	05/12/2011
Title:	IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

Patent #:	9044507	Issue Dt:	06/02/2015	Application #:	12735754	Filing Dt:	08/13/2010
Publication #:	US20110111502	Pub Dt:	05/12/2011
Title:	ELIMINATION OF IMMUNE RESPONSES TO VIRAL VECTORS

Patent #:	9394517	Issue Dt:	07/19/2016	Application #:	14135630	Filing Dt:	12/20/2013
Publication #:	US20140186297	Pub Dt:	07/03/2014
Title:	CD4+ T-CELLS WITH CYTOLYTIC PROPERTIES

Patent #:	10899795	Issue Dt:	01/26/2021	Application #:	14375324	Filing Dt:	07/29/2014
Publication #:	US20140370044	Pub Dt:	12/18/2014
Title:	MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES

Patent #:	10982196	Issue Dt:	04/20/2021	Application #:	14450722	Filing Dt:	08/04/2014
Publication #:	US20140377299	Pub Dt:	12/25/2014
Title:	IMMUNOTHERAPY TARGETING INTRACELLULAR PATHOGENS

Patent #:	10617748	Issue Dt:	04/14/2020	Application #:	14589134	Filing Dt:	01/05/2015
Publication #:	US20150110821	Pub Dt:	04/23/2015
Title:	IMMUNOGENIC CONTROL OF TUMOURS AND TUMOUR CELLS

Patent #:	9861661	Issue Dt:	01/09/2018	Application #:	14686855	Filing Dt:	04/15/2015
Publication #:	US20150216901	Pub Dt:	08/06/2015
Title:	ELIMINATION OF IMMUNE RESPONSES TO VIRAL VECTORS

Patent #:	10662232	Issue Dt:	05/26/2020	Application #:	14976259	Filing Dt:	12/21/2015
Publication #:	US20160194367	Pub Dt:	07/07/2016
Title:	IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	16726411	Filing Dt:	12/24/2019
Publication #:	US20200179499	Pub Dt:	06/11/2020
Title:	STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS

Patent #:	NONE	Issue Dt:		Application #:	16804288	Filing Dt:	02/28/2020
Publication #:	US20200270331	Pub Dt:	08/27/2020
Title:	IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

Patent #:	11718650	Issue Dt:	08/08/2023	Application #:	16848086	Filing Dt:	04/14/2020
Publication #:	US20200317742	Pub Dt:	10/08/2020
Title:	IMMUNOGENIC PEPTIDES AND THEIR USE IN IMMUNE DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	17130192	Filing Dt:	12/22/2020
Publication #:	US20210188913	Pub Dt:	06/24/2021
Title:	MODIFIED EPITOPES FOR BOOSTING CD4+ T-CELL RESPONSES

Assignors

Exec Dt:

06/10/2021

Exec Dt:

07/10/2021

Assignee

AVENUE PRÉ-AILY 14

LIÈGE, BELGIUM 4031

Correspondence name and address
	NIXON & VANDERHYE, PC
	901 N. GLEBE ROAD
	SUITE 1100
	ARLINGTON, VA 22203

Search Results as of: 06/01/2024 06:17 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6